Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for postoperative ascites after liver resection
jRCTs061220114Completed
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tolvaptan in hepatic neoplasm and ascites. Primary endpoint: Maximum perioperative weight change. Started Jun 2023; status: completed.
02
Drugs
tolvaptan
03
Conditions
hepatic neoplasmascites
Beyond the preview
Go deeper on jRCTs061220114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220114.